Finance

Lists
ALT:NASDAQ
Altimmune Inc
$2.06
+1.73%
(+0.035) 1D
Nov 3, 12:45:44 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALT...
Open
$2.03
High
$2.08
Low
$2.03
Mkt. cap
399.73M
Avg. vol.
3.73M
Volume
795.05K
52-wk high
$6.44
52-wk low
$1.99
EPS
-$0.78
Beta
0.16
Shares outstanding
194.52M
No. of employees
57
Open
$2.03
High
$2.08
Low
$2.03
Mkt. cap
399.73M
Avg. vol.
3.73M
Volume
795.05K
52-wk high
$6.44
52-wk low
$1.99
EPS
-$0.78
Beta
0.16
Shares outstanding
194.52M
No. of employees
57
News stories
From web sources and news partners
About Altimmune Inc
CEOJerry Durso
Employees57
Founded1997
HeadquartersGaithersburg, Maryland, United States
SectorBiotechnology
Websitealtimmune.com
Analyst ratings
Based on 5 analysts giving stock ratings to ALT in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ALT in the last 3 months.
Highest
Current $2.06
$28.00 (+1,262.53%)
Average
$21.25 (+934.06%)
Lowest
$17.00 (+727.25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$20.00
+873.2%
10/08/2026
Liisa Bayko
Evercore ISI
Buy
Maintained
$17.00
+727.3%
09/24/2026
Michael DiFiore
Evercore ISI
Buy
Maintained
$17.00
+727.3%
09/24/2026
Eliana Merle
Barclays
Buy
Maintained
$20.00
+873.2%
08/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
$28.00
+1,262.5%
08/13/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
08/12/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
07/29/2026
Thomas Smith
Leerink Partners
Buy
Maintained
$10.00
+386.6%
07/28/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$11.00
+435.3%
05/14/2026
Corinne Johnson
Goldman Sachs
Hold
Upgraded
$2.50
+21.7%
04/24/2026
William Wood
B. Riley Securities
Buy
Maintained
$13.00
+532.6%
03/06/2026
Boris Peaker
JonesTrading
Buy
Initiated
$7.00
+240.6%
02/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.00K
26.00K
-
-
Cost of goods sold
14.96M
18.41M
15.48M
17.86M
Cost of revenue
14.96M
18.41M
15.48M
17.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.90M
10.51M
8.05M
7.57M
Operating expense
5.90M
10.51M
8.05M
7.57M
Total operating expenses
20.86M
28.92M
23.54M
25.43M
Operating income
-20.86M
-28.89M
-23.54M
-25.43M
Other non operating income
-86.00K
-27.00K
-152.00K
-25.00K
EBT including unusual items
-19.01M
-27.36M
-22.56M
-22.82M
EBT excluding unusual items
-19.01M
-27.36M
-21.85M
-22.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.01M
-27.36M
-22.56M
-22.82M
Net profit margin
-380,280.00%
-105,223.08%
-
-
Earnings per share
-0.21
-0.27
-0.18
-0.12
Interest and investment income
2.43M
2.44M
2.90M
4.53M
Interest expense
-495.00K
-876.00K
-1.07M
-1.10M
Net interest expenses
1.93M
1.56M
1.83M
3.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.83M
-28.87M
-23.51M
-25.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps